99 related articles for article (PubMed ID: 20392987)
1. MMP inhibition blocks fibroblast-dependent skin cancer invasion, reduces vascularization and alters VEGF-A and PDGF-BB expression.
Woenne EC; Lederle W; Zwick S; Palmowski M; Krell H; Semmler W; Mueller MM; Kiessling F
Anticancer Res; 2010 Mar; 30(3):703-11. PubMed ID: 20392987
[TBL] [Abstract][Full Text] [Related]
2. Pyrazolo-pyrimidine-derived c-Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signaling.
Donnini S; Monti M; Castagnini C; Solito R; Botta M; Schenone S; Giachetti A; Ziche M
Int J Cancer; 2007 Mar; 120(5):995-1004. PubMed ID: 17131343
[TBL] [Abstract][Full Text] [Related]
3. Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells.
Mueller MM; Fusenig NE
Differentiation; 2002 Dec; 70(9-10):486-97. PubMed ID: 12492491
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor-B normalizes micromorphology and vessel function in vascular endothelial growth factor-A-induced squamous cell carcinomas.
Lederle W; Linde N; Heusel J; Bzyl J; Woenne EC; Zwick S; Skobe M; Kiessling F; Fusenig NE; Mueller MM
Am J Pathol; 2010 Feb; 176(2):981-94. PubMed ID: 20042679
[TBL] [Abstract][Full Text] [Related]
5. Effects of selective MMP-13 inhibition in squamous cell carcinoma depend on estrogen.
Meides A; Gutschalk CM; Devel L; Beau F; Czarny B; Hensler S; Neugebauer J; Dive V; Angel P; Mueller MM
Int J Cancer; 2014 Dec; 135(12):2749-59. PubMed ID: 24676718
[TBL] [Abstract][Full Text] [Related]
6. Cell type specific interleukin-6 induced responses in tumor keratinocytes and stromal fibroblasts are essential for invasive growth.
Depner S; Lederle W; Gutschalk C; Linde N; Zajonz A; Mueller MM
Int J Cancer; 2014 Aug; 135(3):551-62. PubMed ID: 23165423
[TBL] [Abstract][Full Text] [Related]
7. Distinct progression-associated expression of tumor and stromal MMPs in HaCaT skin SCCs correlates with onset of invasion.
Vosseler S; Lederle W; Airola K; Obermueller E; Fusenig NE; Mueller MM
Int J Cancer; 2009 Nov; 125(10):2296-306. PubMed ID: 19610062
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants.
Vosseler S; Mirancea N; Bohlen P; Mueller MM; Fusenig NE
Cancer Res; 2005 Feb; 65(4):1294-305. PubMed ID: 15735015
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapeutic alteration of VEGF-/PDGF- and PDGF-Rα/β expression by imatinib in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
Schultz JD; Mühlheim K; Erben P; Hofheinz RD; Faber A; Thorn C; Sommer JU; Hörmann K; Sauter A
Oncol Rep; 2011 Nov; 26(5):1099-109. PubMed ID: 21805039
[TBL] [Abstract][Full Text] [Related]
10. Reversion of tumor phenotype in surface transplants of skin SCC cells by scaffold-induced stroma modulation.
Willhauck MJ; Mirancea N; Vosseler S; Pavesio A; Boukamp P; Mueller MM; Fusenig NE; Stark HJ
Carcinogenesis; 2007 Mar; 28(3):595-610. PubMed ID: 17056607
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells.
Lederle W; Stark HJ; Skobe M; Fusenig NE; Mueller MM
Am J Pathol; 2006 Nov; 169(5):1767-83. PubMed ID: 17071599
[TBL] [Abstract][Full Text] [Related]
12. MMP-10 (Stromelysin-2) and MMP-21 in human and murine squamous cell cancer.
Boyd S; Virolainen S; Pärssinen J; Skoog T; van Hogerlinden M; Latonen L; Kyllönen L; Toftgard R; Saarialho-Kere U
Exp Dermatol; 2009 Dec; 18(12):1044-52. PubMed ID: 19601983
[TBL] [Abstract][Full Text] [Related]
13. Effect of heparin and related glycosaminoglycan on PDGF-induced lung fibroblast proliferation, chemotactic response and matrix metalloproteinases activity.
Sasaki M; Kashima M; Ito T; Watanabe A; Sano M; Kagaya M; Shioya T; Miura M
Mediators Inflamm; 2000; 9(2):85-91. PubMed ID: 10958381
[TBL] [Abstract][Full Text] [Related]
14. Optical tomography of MMP activity allows a sensitive noninvasive characterization of the invasiveness and angiogenesis of SCC xenografts.
Al Rawashdeh W; Arns S; Gremse F; Ehling J; Knüchel-Clarke R; Kray S; Spöler F; Kiessling F; Lederle W
Neoplasia; 2014 Mar; 16(3):235-46, 246.e1. PubMed ID: 24784000
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
O'Grady A; Dunne C; O'Kelly P; Murphy GM; Leader M; Kay E
Histopathology; 2007 Dec; 51(6):793-804. PubMed ID: 18042068
[TBL] [Abstract][Full Text] [Related]
17. Differential stromal regulation of MMP-1 expression in benign and malignant keratinocytes.
Airola K; Fusenig NE
J Invest Dermatol; 2001 Jan; 116(1):85-92. PubMed ID: 11168802
[TBL] [Abstract][Full Text] [Related]
18. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
19. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.
Tang Y; Nakada MT; Kesavan P; McCabe F; Millar H; Rafferty P; Bugelski P; Yan L
Cancer Res; 2005 Apr; 65(8):3193-9. PubMed ID: 15833850
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of a mixture containing ascorbic acid, lysine, proline and green tea extract on critical parameters in angiogenesis.
Roomi MW; Roomi N; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2005 Oct; 14(4):807-15. PubMed ID: 16142336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
